Prostaglandin E1 administration post liver transplantation and renal outcomes: A retrospective single center experience

Table 3 Renal and long-term outcomes

Variable	PGE1 (n = 44)	Non-PGE1 (n = 101)	P value
EGFR at 6 months (mL/minute) (mean ± SD)	54.8 ± 21.6	62 ± 21.4	0.09
EGFR at 1 year (mL/minute) (mean ± SD)	63.7 ± 20.7	62.8 ± 20.3	0.85
The 30-day readmission	31.6	27.4	0.64
The 90-day readmission	29.6	13.1	0.02
Liver transplant complications
Hepatic artery thrombosis	4.6	1	0.17
Biliary complications	27.3	23	0.58
Rejection of liver graft	18.2	13	0.42
Cardiomyopathy	0	3	0.25
Liver graft survival at 1 year	87.5	98.9	0.005
Patient survival at 1 year	96.9	97.8	0.77
Follow up duration (days) (mean ± SD)	615.3 ± 569.4	1092.8 ± 877.7	0.002
Overall liver graft survival	95.4	93.9	0.74
Overall patient survival	88.4	86.9	0.81

PGE1: Prostaglandin E1; EGFR: Glomerular filtration rate.